BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36122410)

  • 21. Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusion.
    Orsini E; Alyea EP; Schlossman R; Canning C; Soiffer RJ; Chillemi A; Neuberg D; Anderson KC; Ritz J
    Bone Marrow Transplant; 2000 Mar; 25(6):623-32. PubMed ID: 10734296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expansion of tumor-specific CD8+ T cell clones in patients with relapsed myeloma after donor lymphocyte infusion.
    Orsini E; Bellucci R; Alyea EP; Schlossman R; Canning C; McLaughlin S; Ghia P; Anderson KC; Ritz J
    Cancer Res; 2003 May; 63(10):2561-8. PubMed ID: 12750280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virus-reactive T cells expanded in aplastic anemia eliminate hematopoietic progenitor cells by molecular mimicry.
    Ben Hamza A; Welters C; Stadler S; Brüggemann M; Dietze K; Brauns O; Brümmendorf TH; Winkler T; Bullinger L; Blankenstein T; Rosenberger L; Leisegang M; Kammertöns T; Herr W; Moosmann A; Strobel J; Hackstein H; Dornmair K; Beier F; Hansmann L
    Blood; 2024 Apr; 143(14):1365-1378. PubMed ID: 38277625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal analysis of T-cell receptor repertoires reveals persistence of antigen-driven CD4
    Servaas NH; Zaaraoui-Boutahar F; Wichers CGK; Ottria A; Chouri E; Affandi AJ; Silva-Cardoso S; van der Kroef M; Carvalheiro T; van Wijk F; Radstake TRDJ; Andeweg AC; Pandit A
    J Autoimmun; 2021 Feb; 117():102574. PubMed ID: 33307312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinctive features of the differentiated phenotype and infiltration of tumor-reactive lymphocytes in clear cell renal cell carcinoma.
    Wang QJ; Hanada K; Robbins PF; Li YF; Yang JC
    Cancer Res; 2012 Dec; 72(23):6119-29. PubMed ID: 23071066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effector memory and central memory NY-ESO-1-specific re-directed T cells for treatment of multiple myeloma.
    Schuberth PC; Jakka G; Jensen SM; Wadle A; Gautschi F; Haley D; Haile S; Mischo A; Held G; Thiel M; Tinguely M; Bifulco CB; Fox BA; Renner C; Petrausch U
    Gene Ther; 2013 Apr; 20(4):386-95. PubMed ID: 22739387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell.
    Billadeau D; Ahmann G; Greipp P; Van Ness B
    J Exp Med; 1993 Sep; 178(3):1023-31. PubMed ID: 8350044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of the molecular analysis of the T-cell receptor repertoire in the study of immune-mediated hematologic diseases.
    Plasilova M; Risitano A; Maciejewski JP
    Hematology; 2003 Jun; 8(3):173-81. PubMed ID: 12745651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Change in expression pattern of TCR-CD3 complex in patients with multiple myeloma.
    Li Y; Chen S; Yang L; Chen S; Lin C; Wang L; Lu Y; Geng S; Du X; Schmidt CA
    Hematology; 2011 May; 16(3):143-50. PubMed ID: 21669053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of cells with T cell markers in athymic nude bone marrow and of their in vitro-derived clonal progeny. Comparison with euthymic bone marrow.
    Benveniste P; Chadwick BS; Miller RG; Reimann J
    J Immunol; 1990 Jan; 144(2):411-9. PubMed ID: 2136889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression and Significance of PD-1, PD-L1 and CTLA-4 in the Bone Marrow of Patients with Multiple Myeloma].
    Li QZ; Peng J; Chen HM; Chen ZZ; Zhu ZW; Li LS; Hu GY; Yuan ZH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1803-1809. PubMed ID: 36476907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The bone marrow of myeloma patients is steadily inhabited by a normal-sized pool of functional regulatory T cells irrespectiveof the disease status.
    Foglietta M; Castella B; Mariani S; Coscia M; Godio L; Ferracini R; Ruggeri M; Muccio V; Omedé P; Palumbo A; Boccadoro M; Massaia M
    Haematologica; 2014 Oct; 99(10):1605-10. PubMed ID: 24972771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytotoxic T lymphocytes derived from bone marrow mononuclear cells of multiple myeloma patients recognize an underglycosylated form of MUC1 mucin.
    Noto H; Takahashi T; Makiguchi Y; Hayashi T; Hinoda Y; Imai K
    Int Immunol; 1997 May; 9(5):791-8. PubMed ID: 9184925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of T-cell receptors in multiple sclerosis: clonal expansion and persistence of human T-cells specific for an immunodominant myelin basic protein peptide.
    Wucherpfennig KW; Hafler DA
    Ann N Y Acad Sci; 1995 Jul; 756():241-58. PubMed ID: 7544075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonally Expanded Virus-Specific CD8 T Cells Acquire Diverse Transcriptional Phenotypes During Acute, Chronic, and Latent Infections.
    Kuhn R; Sandu I; Agrafiotis A; Hong KL; Shlesinger D; Neimeier D; Merkler D; Oxenius A; Reddy ST; Yermanos A
    Front Immunol; 2022; 13():782441. PubMed ID: 35185882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes.
    Weyand CM; Schönberger J; Oppitz U; Hunder NN; Hicok KC; Goronzy JJ
    J Exp Med; 1994 Mar; 179(3):951-60. PubMed ID: 8113687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clonal cytotoxic T cells are expanded in myeloma and reside in the CD8(+)CD57(+)CD28(-) compartment.
    Sze DM; Giesajtis G; Brown RD; Raitakari M; Gibson J; Ho J; Baxter AG; Fazekas de St Groth B; Basten A; Joshua DE
    Blood; 2001 Nov; 98(9):2817-27. PubMed ID: 11675356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Broadly applicable TCR-based therapy for multiple myeloma targeting the immunoglobulin J chain.
    Meeuwsen MH; Wouters AK; Wachsmann TLA; Hagedoorn RS; Kester MGD; Remst DFG; van der Steen DM; de Ru AH; van Hees EP; Kremer M; Griffioen M; van Veelen PA; Falkenburg JHF; Heemskerk MHM
    J Hematol Oncol; 2023 Feb; 16(1):16. PubMed ID: 36850001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abundant cytomegalovirus (CMV) reactive clonotypes in the CD8(+) T cell receptor alpha repertoire following allogeneic transplantation.
    Link CS; Eugster A; Heidenreich F; Rücker-Braun E; Schmiedgen M; Oelschlägel U; Kühn D; Dietz S; Fuchs Y; Dahl A; Domingues AM; Klesse C; Schmitz M; Ehninger G; Bornhäuser M; Schetelig J; Bonifacio E
    Clin Exp Immunol; 2016 Jun; 184(3):389-402. PubMed ID: 26800118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oligoclonal expansion of CD8+ CD57+ T cells with restricted T-cell receptor beta chain variability after bone marrow transplantation.
    Gorochov G; Debré P; Leblond V; Sadat-Sowti B; Sigaux F; Autran B
    Blood; 1994 Jan; 83(2):587-95. PubMed ID: 7506956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.